Of the 47 ‘Match’ cases, 17 (36.17%) were identified as novel subtypes by v12.5, including germ cell tumor_germinoma_KIT mutation (GCT_GERM_KIT), germ cell tumor_teratoma (GCT_TERA), neuroepithelial tumor_PATZ1 fusion-positive (NET_PATZ1), neuroepithelial tumor_PLAGL1 fusion-positive (NET_PLAGL1_FUS), and diffuse pediatric-type high-grade glioma_receptor tyrosine kinase 1A-type (pedHGG_RTK1A). Here, FUS is linked to central nervous system cancer.